Alibaba.com's internal trade data for the past year paints a picture of a market in hyper-growth. The number of active buyers (abCnt) for topical pain relief products has surged from 251 to 448, representing a consistent year-over-year growth rate that peaked above 100% in late 2025. This isn't just a spike in interest; it's a structural shift in global demand. The average number of buyer interactions per product (AB rate) has also climbed from 1.39 to 2.48, confirming that each new listing is attracting significantly more serious inquiries. This data, sourced directly from our platform, signals a market where demand is not only growing but also becoming more engaged and conversion-ready.
This macro trend is validated by the global market intelligence. According to Grand View Research, the global pain relief patch market was valued at USD 11.2 billion in 2023 and is projected to expand at a CAGR of 5.2% from 2024 to 2030 [1]. Fortune Business Insights echoes this, forecasting the market to reach USD 15.7 billion by 2032 [2]. This multi-billion dollar opportunity is being fueled by a confluence of factors: an aging global population suffering from chronic pain, a growing preference for non-invasive, self-administered treatments over oral medications, and a heightened focus on personal wellness post-pandemic. For Southeast Asian manufacturers, this represents a golden window to position their traditional formulations on the world stage.

